AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

TELIX PHARMACEUTICALS LTD

15.870

+0.4602.99%

Volume:2.36M

Turnover:37.78M

Market Cap:5.38B

PE:115.93

High:16.270

Open:15.510

Low:15.510

Close:15.410

52wk High:18.220

52wk Low:8.260

Shares:338.72M

Float Shares:275.41M

Volume Ratio:1.30

T/O Rate:0.86%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.137

EPS(LYR):-0.030

ROE:7.36%

ROA:2.71%

PB:7.68

PE(LYR):-524.07

Loading ...

Overview Company News Filings

Telix Doses First US Patients With FDA-Approved Brain Cancer Imaging Drug

MT Newswires Live

How Investors Are Reacting To Telix Pharmaceuticals (ASX:TLX) Fast Track Nod

Simply Wall St.

Liontown And 2 Other Australian Growth Stocks To Watch

Simply Wall St.

3 Australian Founder Led Growth Stocks To Own In October 2026

Simply Wall St.

IBA and Telix Strengthen Ties Through Agreement to Distribute ARTMS QIS

Iba - Iba and Telix Strengthen Ties Through Agreement to Distribute Artms's Qis

THOMSON REUTERS

IBA Agrees to Distribute Telix Unit Artms’ Quantm Solid-Target Cyclotron Technology Worldwide

Jefferies Raises PT on Australia's Telix Pharma After Deal with ITM Isotope Technologies

Telix Wins FDA Fast Track for BiPASS Pre-Biopsy Prostate Cancer Imaging Study

Telix Pharmaceuticals - Illuccix and Gozellix Approved for Pet Imaging of Psma-Positive Prostate Cancer Lesions

THOMSON REUTERS

Telix Pharmaceuticals Limited-FDA Fast Track for Bipass Pre Biopsy Prostate Imaging

THOMSON REUTERS

Australia's Telix Pharmaceuticals to End Week Lower as ITM Deal Weigh

Capmont Sells ITM Stake as Telix Agrees US$ 1.65 Billion Acquisition

Telix Pharma Rises After ITM Deal Selloff; Citi Backs Share Issuance

Telix Pharmaceuticals Receives ASX Waivers on Share Issuance Timing for Acquisition Consideration

MT Newswires Live

Telix Pharmaceuticals Limited-Grant of Waivers of Listing Rule 7.3.4

THOMSON REUTERS

France's Abivax H1 Net Loss Widens on Higher Expenses Driven by Clinical Programs

Deals of the Day-Mergers and Acquisitions

Australian Shares End Flat as Miners Offset Gains in Banks

Australian Shares Flat; Telix Pharmaceuticals to Acquire German Radiopharmaceutical Biotechnology Company for Initial $1.65 Billion Payment

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/TLX.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"TLX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"TLX.AU\",,,,,undefined,":{"symbol":"TLX.AU","market":"AU","secType":"STK","nameCN":"TELIX PHARMACEUTICALS LTD","latestPrice":15.87,"timestamp":1791349920000,"preClose":15.41,"halted":0,"volume":2364422,"delay":0,"changeRate":0.029850746268656657,"nameEN":"TELIX PHARMACEUTICALS LTD","floatShares":275410996,"shares":338721355,"eps":0.13689543327879677,"marketStatus":"Not Yet Opened","change":0.46,"latestTime":"10-07 16:12:00 AEDT","open":15.51,"high":16.27,"low":15.51,"amount":37775719,"amplitude":0.049319,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.13689543327879677,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1791414000000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":15.41,"openAndCloseTimeList":[[1791327600000,1791349200000]],"volumeRatio":1.2951816666276974,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"TLX.AU","preClose":15.41,"auctionPrice":15.87,"auctionVolume":342368,"auction":3,"marketStatus":"盘后竞价","timestamp":1791349803597}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"TLX.AU\",,,,,undefined,":{"symbol":"TLX.AU","floatShares":275410996,"roa":"2.71%","roe":"7.36%","lyrEps":-0.030282,"volumeRatio":1.2951816666276974,"shares":338721355,"dividePrice":0,"high":16.27,"amplitude":0.049319,"preClose":15.41,"low":15.51,"week52Low":8.26,"pbRate":"7.68","psRate":"4.20","week52High":18.22,"institutionHeld":0,"latestPrice":15.87,"eps":0.13689543327879677,"divideRate":0,"volume":2364422,"delay":0,"ttmEps":0.13689543327879677,"open":15.51,"prevYearClose":11.2,"prevWeekClose":15.16,"prevMonthClose":15.72,"prevQuarterClose":15.72,"fiveDayClose":15.72,"twentyDayClose":16.69,"sixtyDayClose":16.03},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TLX.AU\",params:#limit:5,,,undefined,":[{"date":"2026-08-20","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787184000000,"name":null,"time":"","dateTimestamp":1787148000000,"actualEps":null},{"date":"2026-02-19","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1771455600000,"name":null,"time":"","dateTimestamp":1771419600000,"actualEps":null},{"date":"2026-01-19","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1768777200000,"name":null,"time":"","dateTimestamp":1768741200000,"actualEps":null},{"date":"2025-08-21","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755734400000,"name":null,"time":"","dateTimestamp":1755698400000,"actualEps":null},{"date":"2025-02-19","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1739919600000,"name":null,"time":"","dateTimestamp":1739883600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TLX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TLX.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673055551","title":"Telix Doses First US Patients With FDA-Approved Brain Cancer Imaging Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2673055551","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673055551?lang=en_us&edition=fundamental","pubTime":"2026-10-06 19:25","pubTimestamp":1791285937,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals  said Tuesday it administered the first US doses of Pixclara, a Food and Drug Administration-approved positron emission tomography imaging drug for brain cancer imaging.The initial doses took place at medical centers in Cleveland and Indianapolis, starting the product's commercial availability in the country, the company said.PharmaLogic will be the manufacturing and pharmacy distribution partner to supply finished unit doses to the market, Telix said.The drug, also known as floretyrosine F-18, is used to help differentiate recurrent or progressive glioma from treatment-related changes in patients aged one month and above, it said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LABU","BK4139","BK7067","BK4585","BK4588","TLX.AU","TLX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673105523","title":"How Investors Are Reacting To Telix Pharmaceuticals (ASX:TLX) Fast Track Nod","url":"https://stock-news.laohu8.com/highlight/detail?id=2673105523","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673105523?lang=en_us&edition=fundamental","pubTime":"2026-10-06 18:22","pubTimestamp":1791282120,"startTime":"0","endTime":"0","summary":"In late September 2026, Telix Pharmaceuticals reported that the FDA granted Fast Track designation for its BiPASS program, which studies 68Ga-PSMA-PET imaging plus MRI to refine prostate cancer detection before biopsy, following completion of Phase 3 enrollment for Illuccix and Gozellix in this pre-biopsy setting.\nThe focus on using Illuccix and Gozellix earlier in the diagnostic pathway targets a large pool of men currently undergoing millions of biopsies where up to 75% return negative...","market":"nz","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice1-card/1788937617532","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice1-card/1788937617532"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/how-investors-are-reacting-to-telix-pharmaceuticals-asxtlx-f","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/how-investors-are-reacting-to-telix-pharmaceuticals-asxtlx-f","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4211","ISBC","TLX","BK4139","TLX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672721541","title":"Liontown And 2 Other Australian Growth Stocks To Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2672721541","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672721541?lang=en_us&edition=fundamental","pubTime":"2026-10-04 04:22","pubTimestamp":1791058974,"startTime":"0","endTime":"0","summary":"Australian inflation recently hit 4%, and the Reserve Bank lifted the cash rate target to 4.60%. Higher borrowing costs can punish weak balance sheets, yet fast growing companies where insiders own a meaningful stake can sometimes handle tougher conditions more confidently. This piece looks at three such Australian growth stocks from our high insider ownership screen and explains what their latest numbers and management signals might mean for long term investors.\nThe three stocks discussed...","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/2052000-choice2-card/1788935149464","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/2052000-choice2-card/1788935149464"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-ltr/liontown-shares/news/liontown-and-2-other-australian-growth-stocks-to-watch","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-ltr/liontown-shares/news/liontown-and-2-other-australian-growth-stocks-to-watch","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["GEAR.AU","USD.AU","BK7095","TLX","XAO.AU","VAP.AU","BEAR.AU","IMLC.AU","IOZ.AU","VAS.AU","QRE.AU","BK7137","DACE.AU","XKO.AU","ZYAU.AU","IIGF.AU","STW.AU","SLF.AU","USD","GYG.AU","EIGA.AU","E200.AU","LTR.AU","GIVE.AU","BBOZ.AU","QFN.AU","IISV.AU","OZF.AU","XJO.AU","BK7504","OZR.AU","BK4139","BK7067","TLX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672796025","title":"3 Australian Founder Led Growth Stocks To Own In October 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2672796025","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672796025?lang=en_us&edition=fundamental","pubTime":"2026-10-02 07:23","pubTimestamp":1790896987,"startTime":"0","endTime":"0","summary":"Global bond yields have surged to multi decade highs, pushing borrowing costs up and putting pressure on richly priced Australian growth stocks. That kind of stress often reveals which businesses have conviction from the inside, where founders and executives keep meaningful stakes and stay focused on long term value. This article highlights three fast growing Australian stocks with significant insider ownership that align with that theme.\nThe three fast growing stocks covered below are just a...","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/2053000-choice2-card/1788948823050","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/2053000-choice2-card/1788948823050"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-pdi/pdi-gold-shares/news/3-australian-founder-led-growth-stocks-to-own-in-october-202","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-pdi/pdi-gold-shares/news/3-australian-founder-led-growth-stocks-to-own-in-october-202","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["GEAR.AU","USD","BEAR.AU","DACE.AU","STW.AU","BBOZ.AU","GYG.AU","VAS.AU","IISV.AU","XKO.AU","QFN.AU","SLF.AU","OZF.AU","TLX","BK7067","BK7137","IMLC.AU","TLX.AU","USD.AU","IOZ.AU","E200.AU","GIVE.AU","VAP.AU","BK7104","QRE.AU","XAO.AU","XJO.AU","IIGF.AU","OZR.AU","BK4139","EIGA.AU","PDI.AU","ZYAU.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672346817","title":"IBA and Telix Strengthen Ties Through Agreement to Distribute ARTMS QIS","url":"https://stock-news.laohu8.com/highlight/detail?id=2672346817","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672346817?lang=en_us&edition=fundamental","pubTime":"2026-10-01 13:05","pubTimestamp":1790831106,"startTime":"0","endTime":"0","summary":"BRIEF-IBA And Telix Strengthen Ties Through Agreement To Distribute ARTMS QISOct 1 (Reuters)-Ion Beam Applications SAIBAB.BR:IBA AND TELIX STRENGTHEN TIES THROUGH AGREEMENT TO DISTRIBUTE ARTMS'S QISSource text: nGNE87DkPjFurther company coverage:IBAB.BR","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nFWN45M1B4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672343097","title":"Iba - Iba and Telix Strengthen Ties Through Agreement to Distribute Artms's Qis","url":"https://stock-news.laohu8.com/highlight/detail?id=2672343097","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672343097?lang=en_us&edition=fundamental","pubTime":"2026-10-01 13:01","pubTimestamp":1790830861,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nFWN45M1B4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","TLX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672734387","title":"IBA Agrees to Distribute Telix Unit Artms’ Quantm Solid-Target Cyclotron Technology Worldwide","url":"https://stock-news.laohu8.com/highlight/detail?id=2672734387","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672734387?lang=en_us&edition=fundamental","pubTime":"2026-10-01 12:59","pubTimestamp":1790830760,"startTime":"0","endTime":"0","summary":"IBA agrees to distribute Telix unit ARTMS’ QUANTM solid-target cyclotron technology worldwideIBA signed an agreement with ARTMS, a Telix unit, to distribute the QUANTM Irradiation System solid-target ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDL2gZcHh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","TLX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672178482","title":"Jefferies Raises PT on Australia's Telix Pharma After Deal with ITM Isotope Technologies","url":"https://stock-news.laohu8.com/highlight/detail?id=2672178482","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672178482?lang=en_us&edition=fundamental","pubTime":"2026-10-01 03:04","pubTimestamp":1790795080,"startTime":"0","endTime":"0","summary":"BUZZ-Jefferies raises PT on Australia's Telix Pharma after deal with ITM Isotope Technologies** Jefferies upgrades price target on Telix PharmaceuticalsTLX.AXto A$32 from A$30** Last week, co said it ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nL4N45M1NF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671357228","title":"Telix Wins FDA Fast Track for BiPASS Pre-Biopsy Prostate Cancer Imaging Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2671357228","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671357228?lang=en_us&edition=fundamental","pubTime":"2026-09-30 06:31","pubTimestamp":1790721117,"startTime":"0","endTime":"0","summary":"Telix wins FDA Fast Track for BiPASS pre-biopsy prostate cancer imaging studyTelix received FDA Fast Track designation for BiPASS, a Phase 3 program testing 68Ga PSMA-PET with MRI before prostate biop","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDL8KhHrF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671288372","title":"Telix Pharmaceuticals - Illuccix and Gozellix Approved for Pet Imaging of Psma-Positive Prostate Cancer Lesions","url":"https://stock-news.laohu8.com/highlight/detail?id=2671288372","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671288372?lang=en_us&edition=fundamental","pubTime":"2026-09-30 06:21","pubTimestamp":1790720514,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUE2DKRGG:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","TLX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671228833","title":"Telix Pharmaceuticals Limited-FDA Fast Track for Bipass Pre Biopsy Prostate Imaging","url":"https://stock-news.laohu8.com/highlight/detail?id=2671228833","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671228833?lang=en_us&edition=fundamental","pubTime":"2026-09-30 06:21","pubTimestamp":1790720514,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUE2DKRGG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TLX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670412960","title":"Australia's Telix Pharmaceuticals to End Week Lower as ITM Deal Weigh","url":"https://stock-news.laohu8.com/highlight/detail?id=2670412960","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670412960?lang=en_us&edition=fundamental","pubTime":"2026-09-25 11:14","pubTimestamp":1790306097,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Telix Pharmaceuticals to end week lower as ITM deal weigh** Shares of Telix PharmaceuticalsTLX.AXup 2.2%; shed 10% for the week so far, on track for its worst week since early Feb, if","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nL4N45H04U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669930274","title":"Capmont Sells ITM Stake as Telix Agrees US$ 1.65 Billion Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2669930274","media":"Reuters","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669930274?lang=en_us&edition=fundamental","pubTime":"2026-09-24 21:22","pubTimestamp":1790256127,"startTime":"0","endTime":"0","summary":"Capmont sells ITM stake as Telix agrees US$ 1.65 billion acquisitionCapmont sold its minority stake in portfolio company ITM Isotope Technologies Munich as part of ITM’s merger with Telix Pharmaceutic","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nNDL4NY2qh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669948741","title":"Telix Pharma Rises After ITM Deal Selloff; Citi Backs Share Issuance","url":"https://stock-news.laohu8.com/highlight/detail?id=2669948741","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669948741?lang=en_us&edition=fundamental","pubTime":"2026-09-22 08:59","pubTimestamp":1790038778,"startTime":"0","endTime":"0","summary":"BUZZ-Telix Pharma rises after ITM deal selloff; Citi backs share issuance** Shares of Telix PharmaceuticalsTLX.AXrise as much as 6.8% to A$16.83, their biggest intraday pct gain since September 15** S","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nL4N45E019:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0162691827.USD","BK4207","LU1366192091.USD","LU2417539215.USD","TFNS","LU2462157665.USD","LU1244550494.USD","LU0477156953.USD","LU2125154935.USD","LU0203345920.USD","LU0128525689.USD","BK4588","LU1244550221.USD","LU1162221912.USD","LU1791807156.HKD","TLX.AU","LU0052756011.USD","LU1506573853.SGD","LU0130102774.USD","BK7067","LU0072461881.USD","LU0170899867.USD","LU0310800965.SGD","LU2236285917.USD","BK4559","LU0320765646.SGD","LU1144417596.USD","FTXO","LU1074936037.SGD","LU2456880835.USD","BK4566","LU0130517989.USD","LU1267930227.SGD","LU2360032135.SGD","BK4585","LU2125154778.USD","LU1201861249.SGD","LU0098860793.USD","LU0106831901.USD","LU0314106906.USD","IYF","IE00BSNM7G36.USD","LU0980610538.SGD","BK4504","LU0648001328.SGD","LU1244550577.SGD","LU1668664300.SGD","LU0203347892.USD","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669196280","title":"Telix Pharmaceuticals Receives ASX Waivers on Share Issuance Timing for Acquisition Consideration","url":"https://stock-news.laohu8.com/highlight/detail?id=2669196280","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669196280?lang=en_us&edition=fundamental","pubTime":"2026-09-22 07:25","pubTimestamp":1790033141,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals  sought waivers of an ASX rule to allow shares issued as upfront consideration and future consideration to be issued more than three months after its extraordinary general meeting, as the timing is contingent on completion of closing conditions and achievement of specific milestones, according to a Tuesday Australian bourse filing.The company said ASX granted the waivers, with certain conditions, including that shares tied to the upfront payment are issued once the relevant deal conditions are met, and in any case no later than 12 months after shareholders approve the issue.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","TLX","TLX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669195750","title":"Telix Pharmaceuticals Limited-Grant of Waivers of Listing Rule 7.3.4","url":"https://stock-news.laohu8.com/highlight/detail?id=2669195750","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669195750?lang=en_us&edition=fundamental","pubTime":"2026-09-22 06:24","pubTimestamp":1790029451,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nTUE5NX0VJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","TLX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669716198","title":"France's Abivax H1 Net Loss Widens on Higher Expenses Driven by Clinical Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2669716198","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669716198?lang=en_us&edition=fundamental","pubTime":"2026-09-22 04:27","pubTimestamp":1790022476,"startTime":"0","endTime":"0","summary":"France's Abivax H1 net loss widens on higher expenses driven by clinical programsOverviewFrance biotechnology firm's H1 2026 net loss widened as operating expenses increasedCompany completed royalty c","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nL1N45D0VO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","TLX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669168153","title":"Deals of the Day-Mergers and Acquisitions","url":"https://stock-news.laohu8.com/highlight/detail?id=2669168153","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669168153?lang=en_us&edition=fundamental","pubTime":"2026-09-21 19:37","pubTimestamp":1789990641,"startTime":"0","endTime":"0","summary":"Deals of the day-Mergers and acquisitionsSept 21 (Reuters)-The following bids, mergers, acquisitions and disposals were reported by 0930 GMT on Monday:** US spirits maker Sazerac launched a takeover o","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nL6N45D0CA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1513","TLX.AU","BK7067","BK0188","00769","BK0182","BK0070","BK0233","BK1190","600392","BK0084"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669531491","title":"Australian Shares End Flat as Miners Offset Gains in Banks","url":"https://stock-news.laohu8.com/highlight/detail?id=2669531491","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669531491?lang=en_us&edition=fundamental","pubTime":"2026-09-21 15:25","pubTimestamp":1789975555,"startTime":"0","endTime":"0","summary":"Australian shares end flat as miners offset gains in banksSept 21 (Reuters)-Australian shares ended little changed on Monday as gains in financials offset losses in commodity stocks, while expectation","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nL4N45D0BL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1046248800.SGD","LU0955669360.SGD","LU0345781412.USD","IE00BWDBJ516.SGD","LU0075056555.USD","LU1130305938.SGD","COH.AU","LU0345777147.USD","LU0788109121.HKD","LU0955623706.USD","LU0955648018.USD","LU0971552673.USD","LU1064927863.SGD","LU0266512473.USD","LU0345777659.USD","LU1078025761.USD","BK7508","SG9999002521.SGD","RIO.AU","TLX.AU","LU1481599808.USD","LU2463526074.USD","LU0456854461.SGD","CSL.AU","BK7007","RIO.UK","BK7511","IE00BQJZX424.USD","LU1481600234.SGD","CBA.AU","LU0011963245.USD","LU1302929846.USD","LU1309081286.SGD","LU1430597077.USD","LU0171293334.USD","LU0654597011.USD","LU1023059493.AUD","SG9999001143.SGD","LU0330918003.SGD","LU0612318971.USD","ANZ.AU","LU0831103253.SGD","LU0898667661.SGD","BK7067","LU1487256676.USD","LU0264606111.USD","LU0572939691.SGD","AN3PL.AU","BHP.AU","BK5111"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669015836","title":"Australian Shares Flat; Telix Pharmaceuticals to Acquire German Radiopharmaceutical Biotechnology Company for Initial $1.65 Billion Payment","url":"https://stock-news.laohu8.com/highlight/detail?id=2669015836","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669015836?lang=en_us&edition=fundamental","pubTime":"2026-09-21 14:37","pubTimestamp":1789972642,"startTime":"0","endTime":"0","summary":"Australian shares were flat on Monday, as oil prices eased despite heightened tensions in the Middle East.The S&P/ASX 200 Index was little changed to close at 8,731.90.Brent crude oil futures fell to ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RMS.AU","LU1815336091.USD","ZYAU.AU","DACE.AU","XKO.AU","OZF.AU","BK7104","EIGA.AU","RBA","BK7062","IOZ.AU","GIVE.AU","IISV.AU","LU1303367103.USD","BK7506","PPT.AU","BK4137","BK7067","IMLC.AU","OZR.AU","QFN.AU","IIGF.AU","GEAR.AU","BK4139","LU2098885051.SGD","QRE.AU","LU0757428866.USD","STW.AU","XJO.AU","E200.AU","TLX.AU","VAP.AU","VAS.AU","SLF.AU","BEAR.AU","TLX","XAO.AU","BBOZ.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}